Ramesh, Mayur
Henry Ford Health · Henry Ford Hospital
3 papers on CoChatORCID 0000-0002-1677-3994
Most cited papers
- Verified
Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study
Orenstein, R., Dubberke, E., Hardi, R., Ray, A., Mullane, K., Pardi, D. S., & Ramesh, M. S. (2016) · Clinical Infectious Diseases
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 197
- Verified
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial
Sims, M. D., Khanna, S., Feuerstadt, P., Louie, T. J., Kelly, C. R., Huang, E. S., Hohmann, E. L., Wang, E. E. L., Oneto, C., Cohen, S. H., et al. (2023) · JAMA Network Open
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 83
- Verified
Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis
Miceli, M. H., Goggins, M. I., Chander, P., Sekaran, A. K., Kizy, A. E., Samuel, L., Jiang, H., Thornton, C. R., Ramesh, M., & Alangaden, G. (2015) · Mycoses
Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free